The medical community is excited by retatrutide, a innovative dual GIP and GLP-1 agonist that’s showing impressive results in preliminary studies . This compound works by imitating natural hormones to impact appetite and promote feelings of satisfaction , ultimately contributing to noticeable weight decrease. While currently under evaluation and